Vatech said Tuesday that it recorded 59.4 billion won ($52.9 million) in sales and 12.5 billion won in operating profits in the second quarter of this year.
Exports accounted for 84 percent of total sales, and operating profit also reached a record high compared to previous quarters.
“The sales of 3D diagnostic equipment used in professional high-end medical care such as implants and orthodontics increased significantly in the global market, leading to our earnings growth,” Vatech said.
The company’s sales for 3D diagnostic equipment increased 18 percent year on year in the second quarter. In particular, the company’s Green CT series, which provides a 10-year global warranty policy for the first time in the industry, led the company with steady growth in the low-dose premium brands in the global market.
Up to 63 percent of the company’s sales came from 3D equipment, while 52 percent of the 3D equipment sales came from Green CT.
Vatech plans to strengthen its target marketing and become the number one global dental imaging brand. The company plans to improve the Green CT products as a representative brand of 3D diagnostic equipment around the world. As part of its plan, the company will target the Chinese market, where the company has registered 30 percent growth every year.
Vatech is also stepping up its efforts to reach emerging markets, based on its recent significant progress in Brazil, Mexico, Russia, and India.
“In the second quarter, sales increased in emerging markets such as South America, China, and Asia,” Vatech CEO Hyun Jeong-hoon said. “We will strengthen our global leadership in the dental diagnostic equipment market by launching 3D diagnostic equipment that meets the needs of emerging markets while introducing digital dentistry and strengthening user education and services.”
<© Korea Biomedical Review, All rights reserved.>